Taladoc shares tumble on wider-That-expected loss, disappointing revionue guidance

Taladoc health Shares Fell in Extended Trading on Wednsday after the company reported a wider loss than analysts expected and Issured Disappointing Quarterly Guidance.

Here’s how the company did, Compared to Analysts’ Consensus Estimates from LSEG:

• Loss per share:28 cents vs. 24 cents expected
• Revenue:$ 640.5 Million vs. $ 639.6 Million Expected

Revenue at the Telehealth Company Decreased 3% in the fourth Quarter from $ 660.5 Million during the same period last year, according to a release. Taladoc’s Net Loss Widened to $ 48.4 Million, or 28 cents per share, from a loss of $ 28.9 million, or 17 cents per share, a year ago.

Taladoc is in the middle of a deep slumpWith its stock price Dropping in Each of the Past Four Years Due to Hefty Competition in Remote Health, Challenges at Mental Health Division Betterhelp and HIGH Operating Costs.

When Taladoc Acquired Digital Health Company Livongo in 2020, The Companies Had A Combined Enterprise Value of $ 37 BillionTaladoc’s Market Cap Was Around $ 1.9 billion as of market close on Wednsday.

“As we look forward in 2025, execution will continue to be a top priority as we advance efforts to unlock growth options and position the company for long term success,” Divita said in the statement. “We will also remin focused on our cost structure, building on the significant improvements achieved in 2024 over the prior year.”

Taladoc reported Adjusted Earnings of $ 74.8 Million in Its Fourth Quarter, A 35% decrease from a year ago. Adjusted Earnings for the company’s integrated care segment Declined 5% to $ 53.2 Million, and Betterhelp Saw Adjusted Earnings Drop 63% to $ 21.7.7 Million.

For the first Quarter, Teladoc said it expects revionue of Between $ 608 Million and $ 629 Million, While Analysts Were Expecting $ 632.9 Million. The company said adjusted earnings will be betteren $ 47 million and $ 59 million for the period.

Earlier this month, Taladoc announced It will acquire preventative care company Catapult health In an all-cash deal for $ 65 million. Taladoc said its outlook incluses the anticipated contribution from the deal but not the effect of potential impairments or purchase accounting. Taladoc said the acquisition should close at the end of the month.

Taladoc will host its Quarterly Call with Investors at 4:30 PM Et.

– CNBC’s Bertha Coombs Contributed to this Report.